Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

SEMAGLUTIDE vs SENSIPAR: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

SEMAGLUTIDE vs SENSIPAR: Safety Overview

Metric SEMAGLUTIDE SENSIPAR
Total FAERS Reports 59,604 577
Deaths Reported 792 82
Death Rate 1.3% 14.2%
Hospitalizations 11,258 52
Average Patient Age 59.1 yrs 62.8 yrs
% Female Patients 66.6% N/A
FDA Approval Date Apr 9, 2019 N/A
Manufacturer Novo Nordisk N/A
Route ORAL N/A
Marketing Status Discontinued N/A